DEcancer: Machine learning framework tailored to liquid biopsy based cancer detection and biomarker signature selection
Cancer is a leading cause of mortality worldwide. Over 50% of cancers are diagnosed late, rendering many treatments ineffective. Existing liquid biopsy studies demonstrate a minimally invasive and inexpensive approach for disease detection but lack parsimonious biomarker selection, exhibit poor canc...
Main Authors: | Halner, A, Hankey, L, Liang, Z, Pozzetti, F, Szulc, D, Mi, E, Liu, G, Kessler, BM, Syed, J, Liu, PJ |
---|---|
Formato: | Journal article |
Idioma: | English |
Publicado: |
Cell Press
2023
|
Títulos similares
-
Rationale for early detection of EWSR1 translocation-associated sarcoma biomarkers in liquid biopsy
por: Clanchy, FIL
Publicado: (2021) -
Gut feelings about α-synuclein in gastrointestinal biopsies: biomarker in the making?
por: Ruffmann, C, et al.
Publicado: (2016) -
Multiple signatures of a disease in potential biomarker space : getting the signatures consensus and identification of novel biomarkers
por: Ow, Ghim Siong, et al.
Publicado: (2018) -
Gut feeling about alpha-synuclein in gastro-intestinal biopsies: biomarker in the making?
por: Ruffmann, C, et al.
Publicado: (2015) -
Comparison of Immunohistochemical Markers in Core Needle Biopsy and Excisional Biopsy in Breast Carcinoma
por: ALFATIH P.,, et al.
Publicado: (2015)